Flunixin Meglumine
AgriLabs announces the United States Food and Drug Administration approval of FluNix-D (flunixin meglumine) for use in lactating dairy cows.
AgriLabs announces the United States Food and Drug Administration approval of FluNix-D (flunixin meglumine) for use in lactating dairy cows.
FluNix-D is a non-steroidal inflammatory drug that provides producers with a safe and effective support therapy for their dairy cows by reducing the fever and inflammation caused by bovine respiratory disease and endotoxemia.
The product may be administered intravenously or intramuscularly. The compound breaks down quickly in the animal's body and is cleared from the bloodstream via urine.
The product has a 36-hour milk withdrawal and four-day meat withdrawal in lactating dairy cows.
Flunixin meglumine has been approved for horses as therapy for inflammation, pyrexia and colic. It later was cleared for use in beef cattle and non-lactating dairy cows.
For fastest response, call
(800) 542-8916
